These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 6352644

  • 41. Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients.
    Ramphal R, Kramer BS, Rand KH, Weiner RS, Shands JW.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():81-8. PubMed ID: 6352659
    [Abstract] [Full Text] [Related]

  • 42. Beta-lactam regimens for the febrile neutropenic patient.
    Bodey GP, Fainstein V, Elting LS, Anaissie E, Rolston K, Khardori N, Kantarjian H, Plager C, Murphy WK, Holmes F.
    Cancer; 1990 Jan 01; 65(1):9-16. PubMed ID: 2403484
    [Abstract] [Full Text] [Related]

  • 43. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Fanci R, Paci C, Martinez RL, Fabbri A, Pecile P, Leoni F, Longo G.
    J Chemother; 2000 Jun 01; 12(3):232-9. PubMed ID: 10877519
    [Abstract] [Full Text] [Related]

  • 44. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
    Kinsey SE, Machin SJ, Goldstone AH.
    J Hosp Infect; 1990 Apr 01; 15 Suppl A():49-53. PubMed ID: 1971645
    [Abstract] [Full Text] [Related]

  • 45. [Infections in neutropenic children with neoplasms. Case series contribution].
    Giacchino M, Artino RM, Miniero R, Grazia G, Vivalda M, Dotti G, Mattirolo F, Madon E.
    Minerva Pediatr; 1988 Jun 01; 40(6):339-44. PubMed ID: 3054471
    [No Abstract] [Full Text] [Related]

  • 46. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R, DePauw B, Berman S, Keating A, Ho W.
    J Clin Oncol; 2000 Nov 01; 18(21):3690-8. PubMed ID: 11054442
    [Abstract] [Full Text] [Related]

  • 47. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 48. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
    Louie TJ, Chubb H, Bow EJ, Conly JM, Harding GK, Rayner E, James M.
    Rev Infect Dis; 1985 Jul 01; 7 Suppl 4():S747-61. PubMed ID: 3909333
    [Abstract] [Full Text] [Related]

  • 49. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C, Sirham M, Labarca J, Grebe G, Lira P, Oliva J, Duhalde M, Ocqueteau M, Acuña G.
    Rev Med Chil; 1995 Mar 01; 123(3):312-20. PubMed ID: 8525170
    [Abstract] [Full Text] [Related]

  • 50. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG, Drake TA, Hackbarth CJ, Sande MA.
    J Infect Dis; 1984 Jun 01; 149(6):980-5. PubMed ID: 6429255
    [Abstract] [Full Text] [Related]

  • 51. Monotherapy for empirical management of febrile neutropenic patients.
    Rubin M, Pizzo PA.
    NCI Monogr; 1990 Jun 01; (9):111-6. PubMed ID: 2160613
    [Abstract] [Full Text] [Related]

  • 52. Penicillin or vancomycin plus ceftazidime in febrile neutropenic patients after stem cell transplantation.
    Kargar Samani K, Vandercam B, Straetmans N, Michaux L, Ferrant A.
    Acta Clin Belg; 2000 Jun 01; 55(5):279-84. PubMed ID: 11109643
    [Abstract] [Full Text] [Related]

  • 53. Antibiotic therapy in cancer patients with fever and neutropenia.
    N Engl J Med; 1987 Feb 12; 316(7):410-2. PubMed ID: 3543678
    [No Abstract] [Full Text] [Related]

  • 54. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
    Mackie MJ, Reilly JT, Purohit S, Bartzokas CA.
    J Antimicrob Chemother; 1986 May 12; 17 Suppl C():219-24. PubMed ID: 3522529
    [Abstract] [Full Text] [Related]

  • 55. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
    Papayannis AG, Thomopoulos D, Voulgaris E, Scliros P, Gardikas C.
    J Antimicrob Chemother; 1977 Jul 12; 3(4):311-5. PubMed ID: 893240
    [No Abstract] [Full Text] [Related]

  • 56. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
    Verhagen C, De Pauw BE, Williams KJ, Du Bois W.
    Eur J Clin Microbiol Infect Dis; 1988 Apr 12; 7(2):178-82. PubMed ID: 3134208
    [Abstract] [Full Text] [Related]

  • 57. Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.
    Chandrasekar PH, Arnow PM.
    Ann Pharmacother; 2000 Sep 12; 34(9):989-95. PubMed ID: 10981242
    [Abstract] [Full Text] [Related]

  • 58. A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia.
    Mandell LA, Nicolle LE, Ronald AR, Duperval R, Robson HG, Feld R, Vincelette J, Fong I.
    J Antimicrob Chemother; 1983 Jul 12; 12 Suppl A():9-20. PubMed ID: 6352661
    [Abstract] [Full Text] [Related]

  • 59. Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy.
    Dompeling EC, Donnelly JP, Raemaekers JM, Deresinski SC, Feld R, De Pauw BE.
    Infection; 1998 Jul 12; 26(6):349-54. PubMed ID: 9861558
    [Abstract] [Full Text] [Related]

  • 60. Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.
    Smith L, Will AM, Williams RF, Stevens RF.
    J Infect; 1990 May 12; 20(3):201-6. PubMed ID: 2187928
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.